SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-006101
Filing Date
2023-04-18
Accepted
2023-04-18 07:05:13
Documents
14
Period of Report
2023-04-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrns-20230417x8k.htm   iXBRL 8-K 47757
2 EX-99.1 mrns-20230417xex99d1.htm EX-99.1 15399
3 GRAPHIC mrns-20230417xex99d1001.jpg GRAPHIC 8659
  Complete submission text file 0001558370-23-006101.txt   205963

Data Files

Seq Description Document Type Size
4 EX-101.SCH mrns-20230417.xsd EX-101.SCH 3119
5 EX-101.LAB mrns-20230417_lab.xml EX-101.LAB 16592
6 EX-101.PRE mrns-20230417_pre.xml EX-101.PRE 10714
8 EXTRACTED XBRL INSTANCE DOCUMENT mrns-20230417x8k_htm.xml XML 5063
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS, INC. (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 23825471
SIC: 2834 Pharmaceutical Preparations